The DTG has been designed for typical pharmaceutical and bio-tech applications. The unit provides a battery-powered local display of temperature, visible on a large 0.9" LCD display. Numerous fitting choices ensure simple transition from existing bi-metal or other thermometers to the DTG.
The FilterSense particulate sensor is designed for pharmaceutical powder fluid bed dryers and chemical spray dryers. Moisture present in a drying process will not affect operation nor will the buildup of wet powders.
Patent pending silicone-free placard holder is designed for reusable totes, containers, racks, shelves, skids, and pallets. It allows Accucote®, Avery®, Raflatac® and similar labels to be cleanly removed.
The Elix Advantage system is a modular, easily adaptable solution that can be bench-integrated or wall-installed to fit the needs of today’s laboratories.
The XSpress provides R&D users with advanced instrumentation and data acquisition software to analyze compression forces, ejection force and punch displacement.
Bulk bag filler features all-stainless construction finished to sanitary standards, and a pivot-down fill head that enables the operator to connect empty bags at floor level and resume filling operations rapidly.
Multiple Vessel Processing System Designed For Research, Development, Pilot And Clinical Trial BatchesOctober 20, 2008 10:53 am | Product Releases | Comments
The MVP-50 canr replace multiple blending suites. By processing, transporting and storing material in the same vessel, operator and product exposure are reduced. From bins to Twin Shell®s, the system accommodates multiple vessel configurations for powder blending.
CHAPEL HILL, N.C. (AP) Shares of Pozen Inc. shed nearly 29 percent of their value Friday, after the drug developer announced a generic challenge for one of its products and possible regulatory delays for two other compounds. The company's stock dropped to $6.
TOKYO (AP) Japanese drug maker Daiichi Sankyo Co. and U.S. partner Eli Lilly & Co. sought to reassure investors on Friday that a highly anticipated blood thinner remains on track for approval, despite escalating concerns of further delays by federal health regulators.
ALISO VIEJO, Calif. (AP) Valeant Pharmaceuticals International said Friday it received an upfront payment of $125 million for a collaboration with GlaxoSmithKline to develop a new epilepsy treatment. In August, Valeant announced the deal, which includes its late-stage development drug retigabine.
Pfizer Inc. has reached agreements in principle to resolve substantially all of the personal injury cases, consumer fraud cases and state attorneys general claims involving its non-steroidal anti-inflammatory (NSAID) pain medication Bextra, which Pfizer voluntarily withdrew from the U.S.
WASHINGTON (AP) _ The Food and Drug Administration will ask a panel of experts next week whether studies by biotech firm Genzyme Corp. support approval of a new version of its drug Myozyme.
Merck Dedicates Durham Vaccine Manufacturing Facility in Honor of Merck Scientist Maurice R. Hilleman, Ph.D.October 16, 2008 12:05 pm | News | Comments
Merck has announced that its Durham, North Carolina, vaccine manufacturing facility has completed start-up activities and is beginning to validate production processes, a major step toward regulatory approval and licensure of the new facility.
Valeant Pharmaceuticals International has completed its acquisition of Coria Laboratories, Ltd., a privately-held specialty pharmaceutical company focused on dermatology products in the United States.
Reata Pharmaceuticals, Inc. announces that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer.